Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)

ViiV Healthcare · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
hivhiv-infections
hiv infections, two-drug regimen, virologically-suppressed, dolutegravir plus rilpivirine, integrase inhibitor, protease inhibitor, nnrti-sparing, non-nucleoside reverse transcriptase inhibitor, hiv, nucleoside reverse transcriptase inhibitors, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 872401
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.